Cemiplimab for non-small cell lung cancer: Does it work? – Medical News Today
Cemiplimab is a type of immunotherapy that may help in the treatment of non-small cell lung cancer (NSCLC). However, this type of cancer is still usually fatal.In 2021, the Food and Drug Administration (FDA) approved cemiplimab for advanced NSCLC. It is a type of immunotherapy that the FDA previously approved for squamous cell skin cancer. … Read more